\section{Acknowledgments}
We thank J. Roberts for expert clinical review. We thank C. Agnew, J. Fraser, J. Holton, L. Liu, M. Lolicato, B. Mensa, and T. Thaker for technical assistance with crystallographic data collection and processing. We thank L. Liu and T. Thaker for technical assistance with protein preparation and crystallization screens. We thank M. Grabe, A. Kao, and O. Rosenberg for helpful discussions. 

This work was supported by NIH/NHLBI grant F30HL137329 (E.W.T.), a Sarnoff Foundation Fellowship (E.W.T), NIH/NIGMS grant T32GM007618 to the UCSF Medical Scientist Training Program (E.W.T), NIH/NHLBI grant DP2HL123228 (R.C.D.), and American Heart Association grant 17IRG33460152 (R.C.D.).

Beamline 8.3.1 at the Advanced Light Source is operated by the University of California Office of the President, Multicampus Research Programs and Initiatives grant MR-15-328599, the National Institutes of Health (R01 GM124149 and P30 GM124169), Plexxikon Inc., and the Integrated Diffraction Analysis Technologies program of the US Department of Energy Office of Biological and Environmental Research. The Advanced Light Source (Berkeley, CA) is a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the US Department of Energy under contract number DE-AC02-05CH11231, Office of Basic Energy Sciences.